Haemochromatosis

Brissot, Pierre, Pietrangelo, Antonello, Adams, Paul C., de Graaff, Barbara, McLaren, Christine E., Loréal, Olivier·2018·Nature Reviews Disease Primers

Cited by (434)

Items 101–200 of 434

  1. Present and Future Perspectives in the Treatment of Liver Fibrosis
    Lucia Cerrito, Linda Galasso, Jacopo Iaccarino, Alessandro Pizzi, Fabrizio Termite, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco · 2025 · Pharmaceuticals
  2. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining
    Zhengguang Wang, Yaqi Du · 2021 · International Immunopharmacology
  3. Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers
    Hannes Hagström, Nelson Ndegwa, Molly Jalmeus, Mattias Ekstedt, Iris Posserud, Fredrik Rorsman, Nils Nyhlin, Daniel Klintman, Mårten Werner, Hanns–Ulrich Marschall et al. · 2021 · Liver International
  4. HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease
    Raphael R. Fagundes, Arno R. Bourgonje, Shixian Hu, Ruggero Barbieri, Bernadien H. Jansen, Nienke Sinnema, Tjasso Blokzijl, Cormac T. Taylor, Rinse Karel Weersma, Klaas Nico Faber et al. · 2022 · Frontiers in Physiology
  5. Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside
    Yimin Dong, Meng Zheng, Weizhong Ding, Hanfeng Guan, Jun Xiao, Feng Li · 2025 · Redox Biology
  6. What’s Important and New in Hemochromatosis?
    Pierre Brissot, Éolia Brissot · 2020 · Clinical Hematology International
  7. The effect of a natural polyphenol supplement on iron absorption in adults with hereditary hemochromatosis
    Simone Buerkli, Laura Salvioni, Natalie Koller, Christophe Zeder, Maria José Teles, Graça Porto, Jana Helena Habermann, Irina L. Dubach, Florence Vallelian, Beat M. Frey et al. · 2022 · European Journal of Nutrition
  8. Hereditary Hyperferritinemia
    Alberto Piperno, Sara Pelucchi, Raffaella Mariani · 2023 · International Journal of Molecular Sciences
  9. The Crucial Questions on Synovial Biopsy: When, Why, Who, What, Where, and How?
    Francesca Ingegnoli, Lavinia Agra Coletto, Isabella Scotti, Riccardo Compagnoni, Pietro Simone Randelli, Roberto Felice Caporali · 2021 · Frontiers in Medicine
  10. Hereditary Hemochromatosis: A Cardiac Perspective
    Pranay K Joshi, Saawan C Patel, Devarashetty Shreya, Diana I Zamora, Gautami S Patel, Idan Grossmann, Kevin Rodriguez, Mridul Soni, Ibrahim Sange · 2021 · Cureus
  11. In vitro and in vivo translational models for rare liver diseases
    Sharie J. Haugabook, Marc Ferrer, Elizabeth A. Ottinger · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  12. Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver
    Dorothy H. Crawford, Grant A. Ramm, Kim R. Bridle, Amanda Nicoll, Martin Bruce Delatycki, John Kevin Olynyk · 2023 · Hepatology International
  13. Prolonged exposure to welding fumes as a novel cause of systemic iron overload
    Raffaella Mariani, Sara Pelucchi, Valentina Paolini, Michael Belingheri, Filiberto Di Gennaro, Paola Faverio, Michele Augusto Riva, Alberto Pesci, Alberto Piperno · 2021 · Liver International
  14. Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging
    Yan Xu, Weitao Yang, Yi Han, Kexin Bian, Weiwei Zeng, Liangwen Hao, Hui Wang, Ying-Sheng Cheng, Peijun Wang, Bingbo Zhang · 2023 · Small
  15. Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancer
    Jieon Hwang, Areum Park, Chinwoo Kim, Chang Gon Kim, Jaesung Kwak, Byungil Kim, Hyun‐Jin Shin, Minhee Ku, Jaemoon Yang, Ayoung Baek et al. · 2024 · Cell Communication and Signaling
  16. Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet
    John Wagner, Carine Fillebeen, Tina P. Haliotis, Edouard Charlebois, Angeliki Katsarou, Jeannie Mui, Hojatollah Vali, Kostas Pantopoulos · 2019 · PLoS ONE
  17. An anthracene–quinoline based dual-mode fluorometric–colorimetric sensor for the detection of Fe 3+ and its application in live cell imaging
    Tahereh Tehrani, Soraia Meghdadi, Zohreh Salarvand, Behnam Tavakoli, Kiamars Eskandari, Mehdi Amirnasr · 2021 · New Journal of Chemistry
  18. Dietary Iron Overload and Hfe−/− Related Hemochromatosis Alter Hepatic Mitochondrial Function
    Christine Fischer, Chiara Volani, Tímea Komlódi, Markus Seifert, Egon Demetz, Lara Valente de Souza, Kristina Auer, Verena Petzer, Laura von Raffay, Patrizia Lucia Moser et al. · 2021 · Antioxidants
  19. Selective detection of Fe3+ via fluorescent in real sample using aminoanthraquinone resorcin[4]arene-based receptors with logic gate application
    Ronak S Patel, Rubi J Bhadoriya, Krunal Modi, Manoj A. Vora, Mohan N. Patel, Hitesh M. Parekh · 2024 · Talanta
  20. Distinctive modulation of hepcidin in cancer and its therapeutic relevance
    Feng Lin, Alex Tuffour, Guijie Hao, Frank Peprah Addai, Aixia Huang, Yang Zhou, Haiqi Zhang · 2023 · Frontiers in Oncology
  21. Heme-deficient primitive red blood cells induce HSPC ferroptosis by altering iron homeostasis during zebrafish embryogenesis
    Peng Lv, Shuai Gao, Feng Liu · 2023 · Development
  22. Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
    André Viveiros, Marlene Panzer, Nadja Baumgartner, Benedikt Schaefer, Armin Finkenstedt, Benjamin Henninger, Igor Theurl, Karin Nachbaur, Günter Weiß, Roland Haubner et al. · 2020 · Liver International
  23. Lipidomics reveals perturbations in the liver lipid profile of iron-overloaded mice
    Haoxuan Ding, Qian Zhang, Xiaonan Yu, Lingjun Chen, Zhonghang Wang, Jie Feng · 2021 · Metallomics
  24. HFE hemochromatosis: an overview about therapeutic recommendations
    Rodolfo Delfini Cançado, Aline Morgan Alvarenga, Paulo Caleb Júnior Lima Santos · 2021 · Hematology Transfusion and Cell Therapy
  25. Pentosan polysulfate to control hepcidin expression in vitro and in vivo
    Michela Asperti, Andrea Denardo, Magdalena Gryzik, Annalisa Castagna, Domenico Girelli, Annamaria Naggi, Paolo Arosio, Maura Poli · 2020 · Biochemical Pharmacology
  26. From Environment to Genome and Back: A Lesson from HFE Mutations
    Raffaela Rametta, Marica Meroni, Paola Dongiovanni · 2020 · International Journal of Molecular Sciences
  27. Control of Systemic Iron Homeostasis by the 3’ Iron‐Responsive Element of Divalent Metal Transporter 1 in Mice
    Elisabeth Tybl, Hiromi Gunshin, Sanjay Gupta, Tomasa Barrientos, Michael Bonadonna, Ferran Celma Nos, Gaël Palais, Zoubida Karim, Mayka Sánchez, Nancy C. Andrews et al. · 2020 · HemaSphere
  28. MRI‐Based Iron Phenotyping and Patient Selection for Next‐Generation Sequencing of Non–Homeostatic Iron Regulator Hemochromatosis Genes
    André Viveiros, Benedikt Schaefer, Marlene Panzer, Benjamin Henninger, Michaela Plaikner, Christian Kremser, André Franke, Sören Franzenburg, Marc P. Hoeppner, Reinhard Stauder et al. · 2021 · Hepatology
  29. HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
    Wei Zhang, Xiaomin Wang, Weijia Duan, Anjian Xu, Xinyan Zhao, Jian Huang, Hong You, Pierre Brissot, Xiaojuan Ou, Jidong Jia · 2020 · Frontiers in Genetics
  30. The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance
    Simon T. Grootendorst, Jonathan R.A. de Wilde, Birgit van Dooijeweert, Annelies J. van Vuren, Wouter W. van Solinge, Roger E. G. Schutgens, Richard van Wijk, Marije Bartels · 2021 · International Journal of Molecular Sciences
  31. Characterization of Two Ferroptosis Subtypes With Distinct Immune Infiltration and Gender Difference in Gastric Cancer
    Junfu Ma, Xin Hu, Yanxin Yao, Liuxing Wu, Chao Sheng, Kexin Chen, Ben Liu · 2021 · Frontiers in Nutrition
  32. Disturbances of Copper and Iron Metabolism
    Jay H. Lefkowitch · 2020 · Elsevier eBooks
  33. Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects
    Olivier Loréal, Thibault Cavey, François Robin, Moussa Kenawi, Pascal Guggenbuhl, Pierre Brissot · 2018 · Pharmaceuticals
  34. Air–blood barrier thickening and alterations of alveolar epithelial type 2 cells in mouse lungs with disrupted hepcidin/ferroportin regulatory system
    Christian Mühlfeld, Joana Neves, Christina Brandenberger, Jan Hegermann, Christoph Wrede, Sandro Altamura, Martina Ulrike Muckenthaler · 2018 · Histochemistry and Cell Biology
  35. Interpreting Iron Homeostasis in Congenital and Acquired Disorders
    Natalia Scaramellini, Dania Patricia Fischer, Anand R. Agarvas, Irene Motta, Martina Ulrike Muckenthaler, Christina Mertens · 2023 · Pharmaceuticals
  36. Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study
    Stephen Charles Bain, Bendix Carstensen, Liselotte Hyveled, Stephanie Valer Seremetis, Frederik Flindt Kreiner, Hanan Amadid, Alice Clark · 2023 · BMJ Open Diabetes Research & Care
  37. T2* map at cardiac MRI reveals incidental hepatic and cardiac iron overload
    Jan Michael Brendel, Alina Kratzenstein, Josephine Berger, Florian Hagen, Konstantin Nikolaou, Meinrad Gawaz, Simon Greulich, Patrick Krumm · 2023 · Diagnostic and Interventional Imaging
  38. Effect of procyanidin on dietary iron absorption in hereditary hemochromatosis and in dysmetabolic iron overload syndrome: A crossover double-blind randomized controlled trial
    Hervé Lobbes, Cécile Gladine, Andrzej Mazur, Bruno Pereira, Christian Dualé, Jean‐Michel Cardot, M. Ruivard · 2019 · Clinical Nutrition
  39. Moderate‐intensity aerobic training reduces cardiac damage attributable to experimental iron overload in rats
    Renata Andrade Ávila, Emilly M. Rossi, Guilherme Mendes de Carvalho, Maiara Krause, André Soares Leopoldo, Maria Tereza Weitzel Dias Carneiro, Leonardo dos SANTOS · 2021 · Experimental Physiology
  40. Progress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice
    Friedrich Alexander von Samson‐Himmelstjerna, Benedikt Kolbrink, Theresa Riebeling, Ulrich Kunzendorf, Stefan Krautwald · 2022 · Cells
  41. Feasibility of Targeted Next-Generation DNA Sequencing for Expanding Population Newborn Screening
    Bennett O. V. Shum, Carel Jacobus Pretorius, Letitia M.F. Sng, Ilya Henner, Paulette Barahona, Emre Basar, Jim McGill, Urs Wilgen, Anna Zournazi, Lilian Downie et al. · 2023 · Clinical Chemistry
  42. High Glucose Increases Lactate and Induces the Transforming Growth Factor Beta-Smad 1/5 Atherogenic Pathway in Primary Human Macrophages
    Kareem Awad, Laura Kakkola, Ilkka Julkunen · 2024 · Biomedicines
  43. Feasibility study and direct extraction of endogenous free metallic cations combining hemodialysis and chelating polymer
    Marco Natuzzi, Coralie Grange, Thomas Gréa, Thomas Brichart, Axel Aigle, Denise Béchet, Benoit Hautefeuille, Eloïse Thomas, Jean‐Yves Ayoub, Jeanne‐Marie Bonnet‐Garin et al. · 2021 · Scientific Reports
  44. MRI Appearance of Focal Lesions in Liver Iron Overload
    Anna Pecorelli, Paola Franceschi, Lorenzo Braccischi, Federica Izzo, Matteo Renzulli, Rita Golfieri · 2022 · Diagnostics
  45. Primary Non-HFE Hemochromatosis: A Review
    Alla Turshudzhyan, David C. Wu, George Y. Wu · 2023 · Journal of Clinical and Translational Hepatology
  46. Micronutrients and risks of three main urologic cancers: A mendelian randomization study
    Yi Lü, Hao Su, Yutao Wang, Hongjun Li · 2023 · Frontiers in Nutrition
  47. Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
    Wen Xu, Dongfan Wei, Xiuzu Song · 2024 · Scientific Reports
  48. Prevalence of HFE ‐related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection
    Gérald Le Gac, Virginie Scotet, Isabelle Gourlaouen, Carine L’Hostis, Marie-Christine Mérour, Zoubida Karim, Yves Deugnier, Edouard Bardou‐Jacquet, Thibaud Lefèbvre, Suzanne Assari et al. · 2022 · Alimentary Pharmacology & Therapeutics
  49. Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia
    Giulia Ravasi, Sara Pelucchi, Francesca Bertola, Martina Maria Capelletti, Raffaella Mariani, Alberto Piperno · 2021 · Genes
  50. Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China
    Liyan Wu, Wei Zhang, Yanmeng Li, Donghu Zhou, Bei Zhang, Anjian Xu, Zhen Wu, Lina Wu, Shuxiang Li, Xiaomin Wang et al. · 2021 · Orphanet Journal of Rare Diseases
  51. Iron homeostasis governs erythroid phenotype in Polycythemia Vera
    Cavan Bennett, Victoria E. Jackson, Anne Pettikiriarachchi, Thomas Hayman, Ute Schaeper, Gemma Moir-Meyer, Katherine Fielding, Ricardo Ataíde, Danielle B. Clucas, Andrew Baldi et al. · 2023 · Blood
  52. Overview of Ankle Arthropathy in Hereditary Hemochromatosis
    Sara Calori, Chiara Comisi, Antonio Mascio, Camillo Fulchignoni, Elisabetta Pataia, Giulio Maccauro, Tommaso Greco, Carlo Perisano · 2023 · Medical Sciences
  53. Identification of Variants Associated With Rare Hematological Disorder Erythrocytosis Using Targeted Next-Generation Sequencing Analysis
    Aleša Kristan, Tadej Pajič, Aleš Maver, Tadeja Režen, Tanja Kunej, Rok Količ, Andrej Vuga, Martina Fink, Špela Žula, Helena Podgornik et al. · 2021 · Frontiers in Genetics
  54. Patient Blood Management in der Geburtsvorbereitung, Geburtshilfe und postpartalen Phase
    Philipp Helmer, Tobias Schlesinger, Sebastian Hottenrott, Michael Papsdorf, Achim Wöckel, Joachim Diessner, Jan Stumpner, Magdalena Sitter, Tobias Skazel, Thomas Erik Wurmb et al. · 2022 · Der Anaesthesist
  55. Haemochromatosis revisited
    Aline Morgan Alvarenga, Pierre Brissot, Paulo Caleb Júnior Lima Santos · 2022 · World Journal of Hepatology
  56. Bronze Diabetes: A Common Genetic Disorder Due to Systemic Iron Overload
    Devajit Mohajan, Haradhan Kumar Mohajan · 2023 · Journal of Innovations in Medical Research
  57. Long-term Outcome of Orthotopic Liver Transplantation in Patients With Hemochromatosis: A Summary of a 30-year Transplant Program
    Eva Maria Dobrindt, Eriselda Keshi, Julian Neulichedl, Wenzel Schöning, Robert Öllinger, Johann Pratschke, Dennis Eurich · 2020 · Transplantation Direct
  58. Movement Disorders and Hematologic Diseases
    Roshni Abee Patel, Deborah A. Hall, Sheila R. Eichenseer, Meagan Bailey · 2020 · Movement Disorders Clinical Practice
  59. Quantifying Brain Iron in Hereditary Hemochromatosis Using R2* and Susceptibility Mapping
    Sean K. Sethi, Soumya Sharma, Sara Gharabaghi, D. Reese, Yongsheng Chen, Paul C. Adams, Mandar Jog, Ewart Mark Haacke · 2022 · American Journal of Neuroradiology
  60. The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis
    Naja Nyffenegger, Anna Flace, Ahmet Varol, Patrick Altermatt, Cédric Doucerain, Hanna Sundström, Franz Dürrenberger, Vania Manolova · 2024 · HemaSphere
  61. Novel loci and biomedical consequences of iron homoeostasis variation
    Elias Allara, Steven Bell, Rebecca Smith, Spencer J. Keene, Dipender Gill, Liam Gaziano, Deisy Morselli Gysi, Feiyi Wang, Vinicius Tragante, Amy M. Mason et al. · 2024 · Communications Biology
  62. Transferrin saturation is independently associated with the severity of obstructive sleep apnea syndrome and hypoxia among obese subjects
    Noémie Le Tallec-Estève, Chloé Rousseau, B. Desrues, Olivier Loréal, Ronan Thibault · 2020 · Clinical Nutrition
  63. Research advances on molecular mechanism and natural product therapy of iron metabolism in heart failure
    Tianqing Zhang, Li Luo, Qi He, Sijie Xiao, Yuwei Li, Junpeng Chen, Tao Qin, Zhenni Xiao, Qingliang Ge · 2024 · European journal of medical research
  64. Juvenile Hemochromatosis: A Case Report and Review of the Literature
    Akiyoshi Takami, Yasuaki Tatsumi, Katsuhisa Sakai, Yasumichi Toki, Katsuya Ikuta, Yuka Oohigashi, Junko Takagi, Koichi Kato, Kazuhisa Takami · 2020 · Pharmaceuticals
  65. Epigenetic Regulation of Ferroportin in Primary Cultures of the Rat Blood-Brain Barrier
    Steinunn Sara Helgudóttir, Lisa Greve Routhe, Annette Burkhart, Katrine Jønsson, Inge Søkilde Pedersen, Jacek Lichota, Torben Moos · 2020 · Molecular Neurobiology
  66. Cell-specific expression of Hfe determines the outcome of Salmonella enterica serovar Typhimurium infection in mice
    Manfred Nairz, Christoph Metzendorf, Maja Vujić Spasić, Anna‐Maria Mitterstiller, Andrea Schroll, David Haschka, Alexander Hoffmann, Laura von Raffay, Richard Sparla, Christian Wolfgang Huck et al. · 2020 · Haematologica
  67. Disorders of Iron Metabolism
    Maria Domenica Cappellini · 2022 · Springer eBooks
  68. An overview of the current evidences on the role of iron in colorectal cancer: a review
    Mohammad Hasan Yousefi, Alireza Masoudi, Masoumeh Saberi Rounkian, Maryam Mansouri, Bita Hojat, Marzieh Kaveh Samani, Razieh Veisi, Parisa Honarvar Bakeshloo, Reza Nosratipour, Hamed Afkhami et al. · 2025 · Frontiers in Oncology
  69. The silent invasion of microplastics polyvinyl chloride and polyethylene terephthalate: Potential impact on osteoporosis
    Yizhou Li, Guanghao Piao, Fengxia Hu, Wenjing Chen, Qian Wang, Xiaoyu Zhang, Hongbo Ling, Junqin Liang · 2025 · Journal of Hazardous Materials
  70. Iron overload in HFE-related hemochromatosis severely impairs Vδ2+ γδ T-cell homeostasis
    Derya Erdoğdu, Ina Becoku, Valerie Huber, Yao Wang, Matthias K. Eyrich, Hisayoshi Hashimoto, Michaela Döring, Johannes Hubertus Schulte, Karin Schilbach · 2025 · Blood
  71. Physiopathological changes of ferritin mRNA density and distribution in hippocampal astrocytes in the mouse brain
    Romain Tortuyaux, Katia Avila‐Gutierrez, Marc Oudart, Noémie Mazaré, Philippe Mailly, Jean‐Christophe Deschemin, Sophie Vaulont, Carole Escartin, Martine Cohen‐Salmon · 2022 · Journal of Neurochemistry
  72. Penetrance, cancer incidence and survival in HFE haemochromatosis—A population‐based cohort study
    Benedikt Schaefer, Lorenz Michael Pammer, Bernhard Erich Pfeifer, Sabrina Barbara Neururer, Maria Rosina Troppmair, Marlene Panzer, Sonja Wagner, Elke Pertler, Christian Gieger, Florian Kronenberg et al. · 2024 · Liver International
  73. Hemochromatosis: Ancient to the Future*
    Paul C. Adams · 2020 · Clinical Liver Disease
  74. EnvIRONmental Aspects in Myelodysplastic Syndrome
    Verena Petzer, Igor Theurl, Günter Weiß, Dominik Georg Friedrich Wolf · 2021 · International Journal of Molecular Sciences
  75. Metal Ion-Based Supramolecular Self-Assembly for Cancer Theranostics
    Bing Chen, Chengchao Chu, En Ren, Huirong Lin, Yang Zhang, Peiyu Wang, Hong Yao, Ai‐Lin Liu, Gang Liu, Xinhua Lin · 2022 · Frontiers in Chemistry
  76. Ironing out macrophages in atherosclerosis
    Lei Wang, Jing Cai, Tong Qiao, Kuanyu Li · 2022 · Acta Biochimica et Biophysica Sinica
  77. Joint manifestations revealing inborn metabolic diseases in adults: a narrative review
    A. Loret, Claire Jacob, Saloua Mammou, Adrien Bigot, Hélène Blasco, Alexandra Audemard‐Verger, Ida Vanessa Döederlein Schwartz, Denis Mulleman, F. Maillot · 2023 · Orphanet Journal of Rare Diseases
  78. Blood donor biobank as a resource in personalised biomedical genetic research
    Jonna Clancy, Jarmo Ritari, Eevaleena Vaittinen, Mikko Arvas, Silja Tammi, FinnGen, Satu Koskela, Jukka Partanen · 2024 · European Journal of Human Genetics
  79. Hemochromatosis—How Not to Overlook and Properly Manage “Iron People”—A Review
    Agnieszka Szczerbińska, Beata Kasztelan‐Szczerbińska, Anna Rycyk, Janusz Kocki, Halina Cichoż‐Lach · 2024 · Journal of Clinical Medicine
  80. Oral Non-absorbable Polymer–Deferoxamine Conjugates for Reducing Dietary Iron Absorption
    Shuolin Cui, Zhi Liu, Tamás Nagy, Elizabeth Oladoyin Agboluaje, May P. Xiong · 2023 · Molecular Pharmaceutics
  81. European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis
    Jennifer Cathcart, Ashis Mukhopadhya · 2023 · Frontline Gastroenterology
  82. Graph Convolutional Neural Network-Based Virtual Screening of Phytochemicals and In-Silico Docking Studies of Drug Compounds for Hemochromatosis
    R. Ani, O. S. Deepa · 2023 · IEEE Access
  83. HFE Related Hemochromatosis: Uncovering the Inextricable Link between Iron Homeostasis and the Immunological System
    Graça Porto, Eugénia Cruz, Maria José Teles, Maria A. B. de Sousa · 2019 · Pharmaceuticals
  84. Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the HFE p.Cys282Tyr mutation
    Aline Morgan Alvarenga, Nathália Kozikas da Silva, Paula Fernanda Silva Fonseca, Théo Gremen Mimary de Oliveira, Jacilene Barbosa da Silva Monteiro, Rodolfo Delfini Cançado, Flávio Augusto Naoum, Carla Luana Dinardo, Pierre Brissot, Paulo Caleb Júnior Lima Santos · 2020 · Blood Cells Molecules and Diseases
  85. Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis
    Ahmed M. Dirweesh, Chimaobi M. Anugwom, Yiting Li, Byron P. Vaughn, John R. Lake · 2020 · European Journal of Gastroenterology & Hepatology
  86. Genetic analysis of 39 erythrocytosis and hereditary hemochromatosis‐associated genes in the Slovenian family with idiopathic erythrocytosis
    Aleša Kristan, Jernej Gašperšič, Tadeja Režen, Tanja Kunej, Rok Količ, Andrej Vuga, Martina Fink, Špela Žula, Saša Anžej Doma, Irena Preložnik Zupan et al. · 2021 · Journal of Clinical Laboratory Analysis
  87. Hfe Gene Knock-Out in a Mouse Model of Hereditary Hemochromatosis Affects Bodily Iron Isotope Compositions
    Emmanuelle Albalat, Thibault Cavey, Patricia Leroyer, Martine Ropert, Vincent Balter, Olivier Loréal · 2021 · Frontiers in Medicine
  88. Hemochromatoses
    Pierre Brissot, Olivier Loréal · 2021 · Journal of Hepatology
  89. Liver Iron Content Determination Using a Volumetric Breath‐Hold Gradient‐Echo Sequence With In‐Line R2 * Calculation
    Arthur Peter Wunderlich, Stefan Andreas Schmidt, Valeria Mauro, Lena Kneller, Stephan Kannengießer, Meinrad Beer, Holger Cario · 2020 · Journal of Magnetic Resonance Imaging
  90. Baicalein Alleviates Iron Overload-Induced Ferroptosis and Osteogenic Blockade in Osteoblasts by Activating the Nrf2/GPX4 Pathway
    Zengfeng Guo, Ningfeng Zhang, Junshen Huang, Wang Zhang, Yawei Hu, Shaochu Chen, Ming Gong, Jianhua zhou, Jiancheng Yang, Jiawen Wu · 2026 · BME Frontiers
  91. Applying trace element geochemistry of archaeological bone to study the coevolution of environmental change and human health in the Roman Empire
    Sean Scott, Martin Merrill Shafer, Joel T. Overdier, Maria Teschler‐Nicola, Peter C. Ramsl, Barry W. Cunliffe, Philip M. Farrell · 2024 · Environmental Research
  92. Advances in Imaging of Diffuse Parenchymal Liver Disease
    Maryam Ghadimi, Roya Rezvani Habibabadi, Bita Hazhirkarzar, Mohammadreza Shaghaghi, Sanaz Ameli, Pegah Khoshpouri, Mounes Aliyari Ghasabeh, Ahmet O. Gurakar, Timothy Michael Pawlik, Ihab R. Kamel · 2020 · Journal of Clinical Gastroenterology
  93. Analysis of The Left Atrial Function Using Two-Dimensional Strain in Patients with Recent Diagnosis of Hereditary Hemochromatosis
    Ariel Karim Saad, Martín Aladio, Florencia Yamasato, Verónica Inés Volberg, Esteban González Ballerga, Juan Antonio Sorda, Jorge R Daruich, Ricardo Alfredo Pérez de la Hoz · 2021 · Current Problems in Cardiology
  94. Absorption of nonheme iron during gastric acid suppression in patients with hereditary hemochromatosis and healthy controls
    Wenke Moris, Pauline L. M. Verhaegh, Jef Verbeek, Dorine W. Swinkels, Coby M. Laarakkers, Ad Masclee, Ger H. Koek, Cees Th.B.M. van Deursen · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  95. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
    Min-Qi Jia, Cha‐Xiang Guan, Jia‐Hao Tao, Yong Zhou · 2022 · Oxidative Medicine and Cellular Longevity
  96. NTBI levels in C282Y homozygotes after therapeutic phlebotomy
    Eleanor M. Ryan, Keith J. Mulready, Erwin T. G. Wiegerinck, Jennifer Lin Russell, Dorine W. Swinkels, Stephen F. Stewart · 2022 · eJHaem
  97. Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in β-Thalassemia Major Patients
    Burhan Abdullah Zaman, Shereen Ibrahim · 2022 · Hemoglobin
  98. In silico analysis suggests disruption of interactions between HAMP from hepatocytes and SLC40A1 from macrophages in hepatocellular carcinoma
    Liang Hu, Chao Wu · 2021 · BMC Medical Genomics
  99. Iron Matryoshka—Haemochromatosis nested in Ferroportin Disease?
    André Viveiros, Benedikt Schaefer, Herbert Tilg, Heinz Zoller · 2019 · Liver International
  100. Long‐term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States
    Peter Lymberopoulos, Sameer Prakash, Anjiya Shaikh, Anshul Bhatnagar, Anthony Kaspa Allam, Karthik Goli, John A. Goss, Fasiha Kanwal, Abbas A. Rana, Kris V. Kowdley et al. · 2022 · Liver Transplantation